Latest Sobi News & Updates

See the latest news and media coverage for Sobi. We track all announcements, press releases, and industry mentions in real time, all in one place.

Sobi

Biopharmaceutical company focused on rare diseases

sobi.com

Headquarters: Stockholm, Sweden
Company type: Public company
Number of employees: 2,400–5,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Sobi

In short: Sobi set a SEK 55bn revenue target for 2030, reported strong financial growth, and announced CEO Guido Oelkers' departure for BioNTech.

Company announcements

August 10 Sobi

Sobi partners with Innate Pharma to license lacutamab

The deal includes a USD 75 million upfront payment, with Sobi obtaining exclusive global commercialization rights and potential full development rights after positive Phase 3 results.

August 6 Sobi

Sobi aims for SEK 55bn revenue by 2030

At its Capital Markets Day, the company outlined a new mid-term outlook and a resilient platform for sustained growth beyond 2030.

August 3 Sobi

Sobi CEO Guido Oelkers to step down in 2027

He will remain CEO until January 2027, when the board will appoint a successor after his nearly 10-year tenure.

July 16 Sobi

Sobi announces Q2 2026 results with revenue growth

Total revenue increased 29% at CER to SEK 7,842 M, driven by haematology and immunology.

Media coverage

September 9 Yahoo Finance

Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome

WALTHAM, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE)-- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the US...

September 8 Pharmaphorum

Sobi sizes up $1.7bn merger with blood cancer biotech CTI

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer...

September 8 ZoneBourse

Arctic initiates coverage of Sobi with a buy recommendation and a price target of 551.24 crowns

Arctic initiates coverage of Sobi with a buy recommendation and a price target of 551.24 crowns...

September 1 Placera.se

Sobi: Profit consensus clearly up after report - target price raised

Sobi reported a net revenue of 7,842 million kronor in the second quarter, 7.0 percent above consensus and an increase of 27.0 percent from the previous...

Never miss news about Sobi

Track Sobi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sobi competitors & trending companies

Browse news for competitors to Sobi and other trending companies.